OBJECTIVE: To investigate the wide variability of ocular manifestations associated with mutations in the COL4A1 gene that encodes collagen IValpha1. METHODS: We clinically evaluated 7 patients from 2 unrelated families in whom ocular features segregated with COL4A1 mutations that were identified by direct sequencing. RESULTS: The G2159A transition (c.2159G>A) that leads to the missense mutation p.Gly720Asp was identified in family A. An ocular phenotype of variable severity was observed in all affected relatives. The missense mutation c.2263G>A, p.Gly755Arg was identified in family B. One patient from family B also displayed notable ocular features. CONCLUSIONS: The COL4A1 mutations may be associated with various ophthalmologic developmental anomalies of anterior segment dysgenesis type, which are reminiscent of Axenfeld-Rieger anomalies (ARA). Cerebrovascular disorders should be added to the list of signs potentially associated with ARA. CLINICAL RELEVANCE: These data suggest that cerebral magnetic resonance imaging may be recommended in the clinical treatment of patients with apparently isolated ARA, even when neurological symptoms or signs are lacking.
OBJECTIVE: To investigate the wide variability of ocular manifestations associated with mutations in the COL4A1 gene that encodes collagen IValpha1. METHODS: We clinically evaluated 7 patients from 2 unrelated families in whom ocular features segregated with COL4A1 mutations that were identified by direct sequencing. RESULTS: The G2159A transition (c.2159G>A) that leads to the missense mutation p.Gly720Asp was identified in family A. An ocular phenotype of variable severity was observed in all affected relatives. The missense mutation c.2263G>A, p.Gly755Arg was identified in family B. One patient from family B also displayed notable ocular features. CONCLUSIONS: The COL4A1 mutations may be associated with various ophthalmologic developmental anomalies of anterior segment dysgenesis type, which are reminiscent of Axenfeld-Rieger anomalies (ARA). Cerebrovascular disorders should be added to the list of signs potentially associated with ARA. CLINICAL RELEVANCE: These data suggest that cerebral magnetic resonance imaging may be recommended in the clinical treatment of patients with apparently isolated ARA, even when neurological symptoms or signs are lacking.
Authors: Louis R Caplan; Juan Arenillas; Steven C Cramer; Anne Joutel; Eng H Lo; James Meschia; Sean Savitz; Elizabeth Tournier-Lasserve Journal: Arch Neurol Date: 2011-05-09
Authors: Gautam Bhave; Christopher F Cummings; Roberto M Vanacore; Chino Kumagai-Cresse; Isi A Ero-Tolliver; Mohamed Rafi; Jeong-Suk Kang; Vadim Pedchenko; Liselotte I Fessler; John H Fessler; Billy G Hudson Journal: Nat Chem Biol Date: 2012-07-29 Impact factor: 15.040
Authors: Elly Verbeek; Marije E C Meuwissen; Frans W Verheijen; Paul P Govaert; Daniel J Licht; Debbie S Kuo; Cathryn J Poulton; Rachel Schot; Maarten H Lequin; Jeroen Dudink; Dicky J Halley; René I F de Coo; Jan C den Hollander; Renske Oegema; Douglas B Gould; Grazia M S Mancini Journal: Eur J Hum Genet Date: 2012-02-15 Impact factor: 4.246
Authors: Mao Mao; Richard S Smith; Marcel V Alavi; Jeffrey K Marchant; Mihai Cosma; Richard T Libby; Simon W M John; Douglas B Gould Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799